Pain, Donation-Related Symptoms and the Trajectory of Recovery in Children after Bone Marrow (BM) Donation Are Influenced By Age (Pre vs. Post-Puberty)

Slides:



Advertisements
Similar presentations
Trend, Risk Factors and Outcome of Thrombotic Microangiopathy in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review 
Advertisements

Topical Ruxolitinib Protects LGR5+ Stem Cells in the Hair Follicle and Ameliorates Skin Graft-Versus-Host Disease  Shuichiro Takahashi, MD, Daigo Hashimoto,
Related PBSC Donors Age >60 Have High Rates of Baseline and Donation-Related Pain and Slow Recovery: First Report from the Related Donor Safety Study.
Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 
Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant  Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,
How to Treat MDS without Stem Cell Transplantation
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program by Michael.
The Effect of the Composition of Unrelated Donor Bone Marrow and Peripheral Blood Progenitor Cell Grafts on Transplantation Outcomes  Nancy H. Collins,
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are.
Recovery and Safety Profiles of Marrow and PBSC Donors: Experience of the National Marrow Donor Program  John P. Miller, Elizabeth H. Perry, Thomas H.
Health-related Quality of Life of Bone Marrow versus Peripheral Blood Stem Cell Donors: A Prespecified Subgroup Analysis from a Phase III RCT—BMTCTN Protocol.
Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E
Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,
NCI, NHLBI/PBMTC First International Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Persistent Immune Deficiency in Pediatric.
Twenty Years of Unrelated Donor Hematopoietic Cell Transplantation for Adult Recipients Facilitated by the National Marrow Donor Program  Chatchada Karanes,
Comparison of Outcomes after HLA-Matched Sibling and Unrelated Donor Transplantation for Children with High-Risk Acute Lymphoblastic Leukemia  Mei-Jie.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors:
Access to Hematopoietic Cell Transplantation in the United States
Biology of Blood and Marrow Transplantation
Peripheral Blood Grafts from Unrelated Donors Are Associated with Increased Acute and Chronic Graft-versus-Host Disease without Improved Survival  Mary.
Navneet S. Majhail, Elizabeth A. Murphy, Nancy A
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd  Bettina P. Iliopoulou, PhD, Katie Hsu, MS, Antonio Pierini, MD, Gordon J. Freeman,
Jane Kempenich, Kelly Buck, John Hermanson, Jason Dehn, MPH 
Treatment of Severe Mucositis Pain with Oral Ketamine Mouthwash
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors  Jo-Anne H. Young, MD, Brent R. Logan,
Jo-Anne H. Young, Brent R. Logan, Juan Wu, John R. Wingard, Daniel J
J. J. Nietfeld, Marcelo C. Pasquini, Brent R
Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized.
Twenty Years of Unrelated Donor Bone Marrow Transplantation for Pediatric Acute Leukemia Facilitated by the National Marrow Donor Program  Margaret L.
Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era  Navneet S. Majhail, Pintip Chitphakdithai,
Distinctions Between Effective and Ineffective AML-Specific Autologous Peripheral Blood (PB) Cytotoxic T-Lymphocytes (CTLs)  Rohtesh S. Mehta, MD MPH.
John R. Wingard, M. D. , Alan K. Leahigh, Dennis Confer, M. D
Biology of Blood and Marrow Transplantation
A Novel Strategy in Managing Post-Liver Transplant Acute Graft-Versus-Host-Disease: The New Era (T)Rojan Horse  Zeyad Kanaan, MD, William Tse, MD, FACP 
Consistent Collection and Processing of Non-Mobilized Mononuclear Cell, Apheresis Products from HLA Haploidentical Bone Marrow Donors for Sequential CD3+
Annelies Billen, Jasmin B. L
Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase.
GVHD Prophylaxis with Post-Transplant High Dose Cyclophosphamide: Impact on Engraftment, Treatment-Related Mortality and Resource Utilization  Nasheed.
Infection Prevention - Visitors and the Best of Intentions
Similar Invasive Fungal Infection Rates and Survival after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Bone Marrow or.
Predonation Health-Related Quality of Life Scores Predict Time to Recovery in Hematopoietic Stem Cell Donors  Annelies Billen, J. Alejandro Madrigal,
Biology of Blood and Marrow Transplantation
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional,
Myeloid Derived Suppressor Cells (MDSC)-like Acute Myeloid Leukemia (AML) Cells Are Associated with Resistance to Cytotoxic Effects of Autologous (Auto)
Race and Ethnicity Influences Collection of Granulocyte Colony–Stimulating Factor– Mobilized Peripheral Blood Progenitor Cells from Unrelated Donors, a.
Hayder Saeed, MD, Michael C
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure of Autologous Recovery Following the First UCBT 
Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902 
Mohammad Alhyari, M. D. , Aymen Bukannan, M. D. , Kimberly Brown, M. D
National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery  Navneet S. Majhail, Lih-Wen Mau,
Importance of Site Preparation in Reducing the Risk of Bacterial Contamination during Bone Marrow Harvest  Maheen Z. Abidi, Cassandra Stoll, Anita D'Souza,
Redesigning Care to Lower Episode Costs in Bone Marrow Transplantation
Karen K. Ballen, Roberta J. King, Pintip Chitphakdithai, Charles D
Biology of Blood and Marrow Transplantation
Systemic Toxoplasmosis Post Allogeneic Stem Cell Transplantation (Allo-SCT): Lessons Learned from HIV?  Marie von Lilienfeld-Toal, MD, Maria Gilleece,
Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA Match  Jason Dehn, Mukta Arora, Stephen Spellman, Michelle Setterholm,
Blood and Marrow Transplant Handbook
Influence of Body Weight on Melphalan Dosing in Autologous Stem Cell Transplantation  Kendall Shultes, Christopher Arp, Keith Stockerl-Goldstein, Kathryn.
Donation Activities and Product Integrity in Unrelated Donor Allogeneic Hematopoietic Transplantation: Experience of the National Marrow Donor Program 
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Heather A. Himburg, PhD, Liman Zhao, Jenny Kan, John P. Chute, M.D. 
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
IL-8 Levels Early after Bone Marrow Transplant are Associated with Later Complications of Stem Cell Transplantation  Nikhil Dole, Nathan Luebbering, Nicholas.
Pain. Pain. (A) Skeletal pain experienced by bone marrow (BM) and peripheral blood stem cell (PBSC) donors at baseline, during the pericollection period,
Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions to Predict Survival  Daniel Weisdorf,
Mary Eapen  Biology of Blood and Marrow Transplantation 
In Memoriam: E. Donnall Thomas
Optimal Donor Selection: Beyond HLA
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less  David F. Stroncek, Bronwen E.
Presentation transcript:

Pain, Donation-Related Symptoms and the Trajectory of Recovery in Children after Bone Marrow (BM) Donation Are Influenced By Age (Pre vs. Post-Puberty) and Sex: Primary Analysis of the Pediatric Toxicity Cohort of the Related Donor Safety Study (RDSafe)  Michael A. Pulsipher, MD, Brent R. Logan, PhD, Deidre M. Kiefer, M.P.H., Pintip Chitphakdithai, PhD, Galen E. Switzer, PhD, Marcie L. Riches, MD, J. Douglas Rizzo, MD, MS, Paolo Anderlini, MD, Susan F. Leitman, MD, James W. Varni, PhD, Hati Kobusingye, MS, RaeAnne M. Besser, BS, Bronwen E. Shaw, MD, PhD, Paul V. O'Donnell, MD, PhD, John P. Miller, MD, PhD, Rebecca J. Drexler, BS, AAS, Roberta J. King, MPH, Mary M. Horowitz, MD, MS, Dennis L. Confer, MD  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S93-S94 (March 2016) DOI: 10.1016/j.bbmt.2015.11.394 Copyright © 2016 Terms and Conditions

Figure 1 Skeletal Pain, Skeletal pain experienced by RDSafe pediatric BM donors by age group at baseline, collection and through follow up. (Skeletal pain represents pain in at least one of the following sites: back, bone, headache, hip, limb, joint, and neck). The severity of Skeletal pain is defined as the maximum grade among these pain sites. Biology of Blood and Marrow Transplantation 2016 22, S93-S94DOI: (10.1016/j.bbmt.2015.11.394) Copyright © 2016 Terms and Conditions

Figure 2 Highest Toxicity Level Across All Body Symptoms. Highest toxicity level of key symptoms (fever in the absence of signs of infection, fatigue, skin rash, local reactions, nausea, vomiting, anorexia, insomnia, dizziness, and syncope) experienced by RDSafe pediatric BM donors by age group, at baseline, collection and during follow up. Biology of Blood and Marrow Transplantation 2016 22, S93-S94DOI: (10.1016/j.bbmt.2015.11.394) Copyright © 2016 Terms and Conditions